| Literature DB >> 32399066 |
Thiago Gonçalves de Souza1, Rafael Yutaka Kuradomi1,2, Suely Marlene Rodrigues3, Sergio Ricardo Batlouni1.
Abstract
Breeding technology is of utmost importance for reproduction of wild fish in captivity for the reintroduction and selective breeding programs purposes. The main challenge is that when applied to wild undomesticated specimens, conventional protocols often cause breeders and/or embryo mortality and spawning failure. In this study, we evaluated the reproductive performance of wild Leporinus friderici, a great importance fish for subsistence fishing in South American rivers, applying conventional and lower-dose hormonal therapies by means of two consecutive experiments. In the first, a conventional (0.5 and 5.5 mg/kg) and a lower carp pituitary extract (CPE) dose (0.5 and 1.0 mg/kg) were applied. In the second, a conventional mammalian GnRH analogue associated with metoclopramide (mGnRHa + MET) (40 µg mGnRHa + 20 mg MET/kg) and a lower dose (4 μg mGnRHa + 2 mg MET/kg and 8 µg + 4 mg of mGnRHa + MET/kg) were applied. Ovulation was observed in all treatments, however, only lower CPE protocol provided viable embryos. High levels of 17α,20β-dihydroxy-4-pregnen-3-one (DHP) and 17β estradiol (E2) detected in conventional, but not in lower CPE dose, at ovulation, might be associated to the mortality of the embryos. The use of lower CPE dose applied here was the best way to obtain L. friderici viable embryos. These results directly contribute to the knowledge about poorly explored effects of reproductive management and hormonal therapies in wild-type breeders, showing that the use of reduced doses may be an alternative to reproductive success.Entities:
Keywords: Linpe method; ovulation; reproduction
Year: 2020 PMID: 32399066 PMCID: PMC7212741 DOI: 10.21451/1984-3143-AR2019-0078
Source DB: PubMed Journal: Anim Reprod ISSN: 1806-9614 Impact factor: 1.807
Experimental design used in this study for Leporinus friderici induced spawning.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
|
|
| |||
| Experiment 1 | Conventional dose | 5 | 2: 2 | 10 | 10 |
| CPE | Low dose | 5 | 2: 2 | 10 | 10 |
| Experiment 2 mGnRHa + MET | Conventional dose | 5 | 2: 2 | 10 | 10 |
| Low dose | 3 | 2: 2 | 6 | 6 | |
CPE: carp pituitary extract. Conventional doses: 0.5 and 5.5 mg/kg (12 hour interval) and low doses: 0.5 and 1.0 mg/kg (6 hour interval); mGnRHa + MET: mammalian analogue gonadotrophin-releasing hormone associated with metoclopramide. Conventional dose: 40 μg mGnRHa + 20 mg MET/kg (single dose) and low dose: 4 μg mGnRHa + 2 mg MET/kg and 8 μg mGnRHa and 4 mg MET/kg (interval between doses of 6 hours).
Experimental design used for Leporinus friderici females induced spawning in this study.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| Experiment 1 | Conventional dose | 0.5 mg | 12 | 5.5 mg |
| CPE | Low dose | 0.5 mg | 6 | 1.0 mg |
| Experiment 2 | Conventional dose | 40 µg + 20 mg | - | - |
| mGnRHa + MET | Low dose | 4 µg + 2 mg | 6 | 8 µg + 4 mg |
CPE: carp pituitary extract; mGnRHa + MET: mammalian analogue gonadotrophin-releasing hormone associated with metoclopramide.
Weight (g) and standard length of Leporinus friderici breeders used in this study.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| Experiment 1 | Conventional dose | 803.0 ± 66.1 A | 30.9 ± 0.6 A | 293.5 ± 43.1 A | 23.4 ± 0.9 A | |
| CPE | Low dose | 656.7 ± 37.1 A | 31.4 ± 0.4 A | 291.9 ± 18.3 A | 23.6 ± 0.6 A | |
| Experiment 2 | Conventional dose | 625.5 ± 86.1 A | 29.3 ± 1.1 A | 270.5 ± 27.0 A | 23.0 ± 0.7 A | |
| mGnRHa + MET | Low dose | 458.2 ± 34.4 A | 28.0 ± 0.9 A | 263.0 ± 18.2 A | 23.8 ± 0.4 A | |
CPE: carp pituitary extract; mGnRHa + MET: mammalian analogue gonadotrophin releasing hormone associated with metoclopramide. Values are presented with mean followed by standard error (mean ± SEM). Different capital letters indicate statistical difference (p < 0.05) between different treatments of the same experiment.
Leporinus friderici reproductive performance of females submitted to two experiments for induced spawning using CPE, experiment “1”, and mGnRHa + MET, experiment “2”.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Experiment 1 | Conventional dose | 254.0 ± 6.9 A | 80 | 110.4 ± 21.2 A | 01.2 ± 0.9 A | 0 |
| CPE | Low dose | 153.5 ± 6.6 B | 100 | 146.8 ± 26.1 A | 74.9 ± 8.3 B | 85.0 ± 5.8 |
| Experiment 2 | Conventional dose | 258.1 ± 4.0 A | 70 | 059.4 ± 21.5 A | 00.8 ± 0.5 A | 0 |
| mGnRHa + MET | Low dose | 158.6 ± 0.0 B | 50 | 052.9 ± 23.9 A | 00.9 ± 0.0 A | 0 |
CPE: carp pituitary extract. mGnRHa + MET: mammalian analogue gonadotrophin-releasing hormone associated with metoclopramide. Values are presented with mean followed by standard error (mean ± SEM). Different capital letters indicate statistical difference (p < 0.05) between different treatments of the same experiment. ATU: “accumulated thermal units” between the first or single injection and fish ovulation. Calculated as the sum of the water temperature (°C) over time (hours) after the second dose; SR: spawning rates; RF: relative fertility rate (number of eggs/gram of fish); FS: fertilization success; HS: hatching success.
Figure 1Photomicrographs of histological sections of Leporinus friderici oocytes considered for ovary volume density evaluation in this sytudy. (A) Pre-vitelogenic (PV) (270.1 ± 8.8 μm); (B) Cortical alveolus oocytes (CA) (478.4 ± 25.0 µm) with prominent alveolos at cell border (thick arrows); (C) Complete vitelogenic oocytes (CV) (692.5 ± 35.9 µm); (D) Oocytes that remained attached to the ovaries, showing germinal vesicle break down (GVBD oocytes) ruptured at the periphery of the cell (Vg); (784.3 ± 29.4 µm); (E) Post-ovulatory follicles (thin arrows); (F) Atretic oocytes (AT). N: nucleus; Nu: Nucleoli.
Figure 2Average percentage values (± SE) of the volume density of different structures within ovaries of Leporinus friderici submitted to conventional (0.5 and 5.5 mg/kg) and low (0.5 mg and 1.0 mg/kg) crude carp pituitary extract (CPE) dose, collected just after spawning. Asterisks indicate significant difference between the percentage of the same structure between treatments (p < 0.05). PV: Pre-vitellogenic; CA: Cortical Alveolus; CV: Complete Vitelogenic; GVBD vitellogenic oocyte with germinal vesicle breakdown; POF: post-ovulatory follicle; AT: atretic oocytes; IT: interstitial tissue.
Figure 3Average percentage values (± SE) of the volume density of different structures within ovaries of Leporinus friderici submitted to conventional (40 µg + 20 mg mGnRHa MET/kg (single dose)) and low (4 μg mGnRHa + 2 mg MET (first dose) and 8 µg + 4 mg of mGnRHa + MET (second dose)/kg) dose, collected just after spawning. Asterisks indicate significant difference between the percentage of the same structure between treatments (p < 0.05). PV: Pre-vitellogenic; CA: Cortical Alveolus; CV: Complete Vitelogenic; GVBD vitellogenic oocyte with germinal vesicle breakdown; POF: post-ovulatory follicle; AT: atretic oocytes; IT: interstitial tissue.
Figure 4(A) Plasma concentrations of 17α-20β-dihydroxy-4-pregnen-3-one and; (B) 17β-estradiol of Leporinus friderici submitted to conventional (0.5 and 5.5 mg/kg) and low (0.5 mg and 1.0 mg/kg) crude carp pituitary extract (CPE) dose and to conventional (40 µg + 20 mg/kg) and low (4 μg + 2 mg and 8 µg + 4 mg/kg) mGnRHa + MET dose. *Significant difference between the same groups in different periods of evaluation.